OMEPRAZOLE

Substance profile for UNII KG60484QX9, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for OMEPRAZOLE
Structure render from PubChem CID 4594

Substance Identity#

UNII
KG60484QX9
Preferred term
OMEPRAZOLE
Registry number
73590-58-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C17H19N3O3S
Chemical structure for OMEPRAZOLE
Structure render from PubChem CID 4594

Chemical And Database Identifiers#

SMILES
COC1=CC2=C(NC(=N2)[S+]([O-])CC3=NC=C(C)C(OC)=C3C)C=C1
RxCUI
7646
PubChem
4594
NCIt
C716
INN ID
5081

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYKinray, LLC Omeprazole Drug Facts3
ACTIVE INGREDIENTKinray, LLC Omeprazole Drug Facts3
ACTIVE INGREDIENTShopRite Omeprazole Delayed Release Tablets 20 mg Drug Facts2
ACTIVE MOIETYShopRite Omeprazole Delayed Release Tablets 20 mg Drug Facts2
ACTIVE MOIETYKmart Corporation Omeprazole Drug Facts4
ACTIVE INGREDIENTKmart Corporation Omeprazole Drug Facts4
ACTIVE MOIETYDZA Brands, LLC Omeprazole Drug Facts4
ACTIVE INGREDIENTDZA Brands, LLC Omeprazole Drug Facts4
ACTIVE MOIETYHarmon Stores Inc. Omeprazole Drug Facts3
ACTIVE INGREDIENTHarmon Stores Inc. Omeprazole Drug Facts3
ACTIVE INGREDIENTOmeprazole DR2
ACTIVE MOIETYOmeprazole DR2
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 19895
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 19895
ACTIVE MOIETYThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
ACTIVE INGREDIENTThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
ACTIVE INGREDIENTOMEPRAZOLE1
ACTIVE MOIETYOMEPRAZOLE1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
ACTIVE MOIETYThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules Omeprazole delayed-release capsules, USP, for oral administration Initial U.S. Approval: 198912
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules Omeprazole delayed-release capsules, USP, for oral administration Initial U.S. Approval: 198912
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE delayed-release capsules USP, for oral use INITIAL U.S. APPROVAL: 19891
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE delayed-release capsules USP, for oral use INITIAL U.S. APPROVAL: 19891
ACTIVE MOIETYThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
ACTIVE INGREDIENTThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
ACTIVE INGREDIENTThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 19891
ACTIVE MOIETYThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 19891
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Omeprazole delayed-release capsules safely and effectively. See full prescribing information for Omeprazole delayed-release capsules. OMEPRAZOLE delayed-release capsules, USP, for oral use Initial U.S. Approval: 198923
ACTIVE MOIETYThese highlights do not include all the information needed to use Omeprazole delayed-release capsules safely and effectively. See full prescribing information for Omeprazole delayed-release capsules. OMEPRAZOLE delayed-release capsules, USP, for oral use Initial U.S. Approval: 198923
ACTIVE MOIETY0022ca14-9177-4fe9-90f3-1d67592d8d6c1
ACTIVE INGREDIENT0022ca14-9177-4fe9-90f3-1d67592d8d6c1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
ACTIVE MOIETYThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
ACTIVE MOIETYThese highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
ACTIVE MOIETYOmeprazole1
ACTIVE INGREDIENTOmeprazole1
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-release Capsules, USP INITIAL U.S. APPROVAL: 19891
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-release Capsules, USP INITIAL U.S. APPROVAL: 19891
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
ACTIVE INGREDIENTHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP "Initial U.S. Approval:".19896
ACTIVE MOIETYHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP "Initial U.S. Approval:".19896
ACTIVE INGREDIENTOmeprazole Delayed Release Tablets, 20 mg3
ACTIVE MOIETYOmeprazole Delayed Release Tablets, 20 mg3
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
ACTIVE INGREDIENTOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 01/21/20091
ACTIVE MOIETYOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 01/21/20091
ACTIVE INGREDIENTThese highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID. ZEGERID (omeprazole/sodium bicarbonate) Powder for Oral Suspension ZEGERID (omeprazole/sodium bicarbonate) Capsules Initial U.S. Approval: 20041
ACTIVE MOIETYThese highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID. ZEGERID (omeprazole/sodium bicarbonate) Powder for Oral Suspension ZEGERID (omeprazole/sodium bicarbonate) Capsules Initial U.S. Approval: 20041
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19893
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19893
ACTIVE MOIETYOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
ACTIVE INGREDIENTOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
ACTIVE MOIETYOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
ACTIVE INGREDIENTOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
ACTIVE MOIETYFULL PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE. OMEPRAZOLE DELAYED-RELEASE (omeprazole) capsule, delayed release for oral use Initial U.S. Approval: 19893
ACTIVE INGREDIENTFULL PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE. OMEPRAZOLE DELAYED-RELEASE (omeprazole) capsule, delayed release for oral use Initial U.S. Approval: 19893
ACTIVE MOIETYOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use See full prescribing information for use INITIAL U.S. APPROVAL: 20072
ACTIVE INGREDIENTOmeprazole Delayed-Release Capsules These highlights do not include all the information needed to use See full prescribing information for use INITIAL U.S. APPROVAL: 20072
ACTIVE MOIETYPrilosec OTC ® omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer1
ACTIVE MOIETYOmeprazole 20 mg1
ACTIVE INGREDIENTOmeprazole 20 mg1
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19891
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19891
ACTIVE INGREDIENTOmeprazole Delayed Release Tablets, 20 mg1
ACTIVE MOIETYOmeprazole Delayed Release Tablets, 20 mg1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 20021
ACTIVE MOIETYThese highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 20021
ACTIVE INGREDIENTOmeprazole Delayed Release Tablets, 20 mg1
ACTIVE MOIETYOmeprazole Delayed Release Tablets, 20 mg1
ACTIVE MOIETYThese highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 20021
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 20021
ACTIVE MOIETYDrug Facts3
ACTIVE INGREDIENTDrug Facts3
ACTIVE MOIETYThese highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 20021
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 20021
ACTIVE MOIETYThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules . OMEPRAZOLE DELAYED-RELEASE CAPSULES INITIAL U.S. APPROVAL: 19892
ACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules . OMEPRAZOLE DELAYED-RELEASE CAPSULES INITIAL U.S. APPROVAL: 19892
ACTIVE MOIETYZEGERID® with Magnesium Hydroxide (omeprazole/sodium bicarbonate/magnesium hydroxide)1
ACTIVE INGREDIENTZEGERID® with Magnesium Hydroxide (omeprazole/sodium bicarbonate/magnesium hydroxide)1
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3741
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3741
ACTIVE MOIETYOMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3379
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3379
ACTIVE MOIETYOMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]430
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]430
ACTIVE INGREDIENTZEGERID (OMEPRAZOLE, SODIUM BICARBONATE) POWDER, FOR SUSPENSION ZEGERID (OMEPRAZIOLE, SODIUM BICARBONATE) CAPSULE [SANTARUS, INC.]32
ACTIVE MOIETYZEGERID (OMEPRAZOLE, SODIUM BICARBONATE) POWDER, FOR SUSPENSION ZEGERID (OMEPRAZIOLE, SODIUM BICARBONATE) CAPSULE [SANTARUS, INC.]32
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [ACTAVIS PHARMA, INC.]31
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [ACTAVIS PHARMA, INC.]31
ACTIVE MOIETYPRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]29
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]23
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]23
ACTIVE INGREDIENTOMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]19
ACTIVE MOIETYOMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]19
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [APOTEX CORP]15
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [APOTEX CORP]15
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED]15
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED]15
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]15
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]15
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [SANDOZ INC]14
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [SANDOZ INC]14
ACTIVE INGREDIENTOMEPRAZOLE/SODIUM BICARBONATE (OMEPRAZOLE, SODIUM BICARBONATE) CAPSULE [PRASCO, LABORATORIES]13
ACTIVE MOIETYOMEPRAZOLE/SODIUM BICARBONATE (OMEPRAZOLE, SODIUM BICARBONATE) CAPSULE [PRASCO, LABORATORIES]13
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.]12
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.]12
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED]11
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED]11
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]11
ACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]11
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]11
ACTIVE MOIETYOMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]11